This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
territories, often serving as a crucial alternative when conventional treatments have failed or as a safer option compared to pharmaceuticals. Today, cannabis-based therapies provide relief to over 6 million Americans registered in medical cannabis programs in 38 states, D.C., and four of the five U.S.
#image_title Medical Marijuana vs. Traditional Pharmaceuticals: A Patient’s Guide to Understanding Your Options When discussing Medical Marijuana for managing chronic pain , Dr. Fernando Fandio-Sende has fielded many questions. Miami patients often ask how it compares to traditional medications they have been taking for years.
United Kingdom-based GW Pharmaceuticals has produced the world’s first approved cannabis-based medicines for the UK, US, and European markets, Sativex® and Epidiolex®. GW Pharmaceuticals’ research on glioblastoma multiforme (GBM) is important and promising. Note: In May 2021, GW Pharmaceuticals was acquired by Jazz Pharmaceuticals.]
Pharmaceutical researchers have their sights set on developing a drug that bypasses CB1 while boosting CB2. Referred to as a “selective CB2 agonist ,” such a compound would appear to have potential as a treatment for scleroderma.
When antidepressants were first introduced in the mid-20 th century, they were a breakthrough in pharmaceuticals. Of the people who take antidepressants, 30% won’t respond to treatment. But what other options do people suffering from depression, particularly treatment-resistant depression, have? What is ketamine treatment?
The use of cannabinoids in the treatment of medical conditions offers major opportunities and challenges to anyone operating in the space. In Europe, there is a clear trend towards the use of more precise formulations of unapproved cannabis products as well as pharmaceutical products.
One of the biggest areas of contention in the public debate about cannabis legalization is the viability of medicinal cannabis as a treatment for many mental health disorders, such as anxiety, depression, bipolar disorder, schizophrenia, and others. Cannabis Is a Unique Substance and Treatment Method. CBD for Mental Health Treatment.
This year, we can and must succeed in passing this essential legislation and protecting the rights of veterans to access medical treatment and serving those who served us. We know medical marijuana can be an effective and safe treatment for veterans and it is time to stop making them seek private, out-of-network physicians to access it.
New Breakthrough Treatment for Opiate Addiction with a Unique Combination of Specific Detox Medications, Vivitrol and Reduction of Pressure to the Brain Stem. According to Neurologist & Addiction Medicine Specialist Dr. Russell Surasky, Tips on New and Advanced System of Addiction Treatment Showing Great Success.
Thus, it enables individualization of medical cannabis regimens that can be evaluated pharmacokinetically and pharmacodynamically by accepted pharmaceutical models.”
Psychiatrists readily prescribe pharmaceuticals over marijuana when a patient is diagnosed with clinical depression. The post Medical Marijuana: An Alternative Treatment for Depression? Antidepressants alter the balance of chemicals in the brain to relieve symptoms of depression. appeared first on.
Poster presentation to address the preclinical cannabidiol derivative for the potential treatment of psychiatric disorders BALTIMORE–(BUSINESS WIRE)–MyMD Pharmaceuticals, Inc. Nasdaq:… Read More.
In either case, there is definitely a connection, and the widening availability for adults to consume cannabis legally for recreational and medicinal purposes has driven public interest into using cannabis for mental health treatment. Between CBD and THC, CBD seems to hold the best potential as a treatment for anxiety compared to THC.
Cannabis is a natural treatment for pain and other symptoms of withdrawal, and has been shown to help manage the side effects of drugs and even has be used as a substitute for prescription medications. Cannabis is a natural treatment for pain and other symptoms of withdrawal. 3] Cannabis is safer than prescription drugs.
Most of the conventional methods for treating migraines involve pharmaceutical medication, which has been known to be accompanied by unwanted side effects, especially from opioid based medication. The post New Research Shows Promising Treatment Results for Migraine Sufferers appeared first on Cannabis Central.
Conventional forms of treatment are often accompanied by adverse side effects but there is hope for effective treatment with fewer side effects. . million of NWS Health funding for their Cannabinoid Therapeutics and Brain and Mind Centre to see if cannabidiol can be that effective treatment for spinal cord injury.
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) raised its full-year 2021 financial guidance based on the acquisition of GW Pharmaceuticals, which was bought on May 5, 2021. regulatory approval, and our new cannabinoid research platform,” said Renée Galá, the chief financial officer of Jazz Pharmaceuticals.
SOURCE InMed Pharmaceuticals Inc. ” Study 755-101-HV is a randomized, vehicle controlled, double-blind, Phase 1 trial, examining the safety and tolerability of two strengths of INM-755 cream in 22 healthy adult volunteers over a 14-day treatment period as part of a randomized, vehicle controlled, double-blind, Phase 1 trial.
A study published in 2008 highlighted that, due to its anti-inflammatory properties and “its ability to knock out nerve pain,” cannabinoid treatment can calm sensitivity and inflammation in the intestinal lining. Once you were diagnosed, what treatment was suggested by your doctor? What treatment do you follow now? Yes, I have.
DUBLIN–(BUSINESS WIRE)– “The Pharmaceutical Cannabis Report: 2nd Edition” report has been added to ResearchAndMarkets.com’s offering. In both Europe and the United States, the sales of unapproved cannabis products such as smokable flower and full spectrum oils dwarf those of approved pharmaceuticals.
Fortunately, one such man, Levi Barker, provided us with some much-needed insight into what the substance is, how it is used in treatment, and more. Many of us have more in our minds than we need… Veriheal: Can you walk us through a typical iboga treatment? One could even say that iboga provides holistic healing.
The Dementia Society of America attributes Dementia to rising healthcare costs as billions are spent each year for treatments and research. Pharmaceuticaltreatments for for Dementia often only target symptoms like pain or depression, but those medicines do not cure or prevent the disease. 9-tetrahydrocannabinol (?9-THC)
Unlike “pharmaceutical CBD”—which contains zero traces of the psychoactive compound THC (tetrahydrocannabinol) and has been FDA-approved to treat Dravet syndrome and Lennox-Gastaut syndrome —artisanal CBD is non-mechanized and usually contains variable amounts of CBD and THC. It goes by the name of “artisanal CBD.” .
As the rate of cancer diagnoses rises worldwide, patients are finding more options with their treatments and healthcare routines. Patients can suffer from the disease itself, or from the side effects of chemotherapy and other pharmaceuticals medications. The post 3 Medical Cannabis Strains Used to Treat Cancer appeared first on.
Valcon Medical A/S Announces Receipt of EU GMP Certification and Start of Commercial Production for Pharmaceutical-Grade Cannabis Concentrates, Intermediary Products, and Medical Formulations (PRNewsfoto/Valcon Medical A/S).
No need to take pills that could do more harm than good; or deal with painful side effects that pharmaceuticals cause. Any documentation that you have will make diagnosing and recommending a treatment plan a lot easier. Therefore, remember to bring along any medical records or documentation of treatment history to your appointment.
.–(BUSINESS WIRE)– $MRNS #MarinusPharma — Marinus Pharmaceuticals, Inc. We look forward to initiating our Phase 3 trial and adding to the body of evidence that supports ganaxolone’s potential as an innovative treatment option for rare epilepsies.”. Chief Medical Officer of Marinus. “We Data Highlights.
Because there is limited or conflicting research about “the true nature of traumatic brain injury and how it causes chronic degenerative problems,” treatment can be a challenging process for many patients. This means that often pharmaceutical medications are experimental.
BALTIMORE–(BUSINESS WIRE)– $MYMD — MyMD Pharmaceuticals, Inc. “Nearly 100,000 people in the United States have idiopathic pulmonary fibrosis (IPF), and although cases continue to climb, there is still a significant unmet need in treatment options for this chronic disease,” said Chris Chapman, M.D.,
Previously, Virginia’s five licensed medical cannabis providers, called pharmaceutical processors, would have been limited to dispensing only oils when they open their doors later this year. “Virginia is moving in the right direction to ensure patients and doctors can choose treatments that are right for them.
With the stigma of cannabis fading by the day, more families are exploring treatments that are more accessible and less pharmaceutical. Continue reading The Potential Of CBD And Cannabis Within The Anxiety And Autism Community at The Fresh Toast.
AI tools are gaining popularity in biomedical research because while it can take years for the pharmaceutical industry to create medicines capable of treating or curing human disease, using AI could vastly accelerate the drug-development process. AI automation opens up the possibility of faster, cheaper pharmaceuticals.
CannaMD has previously reported that cannabis therapies may be more effective for the treatment of PTSD than current pharmaceutical options, may block certain PTSD-triggering memories, and that long-term marijuana use has been […].
Before getting to this news, let’s take a minute to review some of the prior research supporting marijuana for the treatment PTSD. Medical Marijuana: More Effective Than Pharmaceuticals? To date, there is no pharmaceutical product targeted specifically for the treatment of PTSD. Need Your Medical Marijuana Card?
Pharmaceutical and Medical Cannabis Leaders Zambon GmbH and Adven GmbH will Drive Medical Cannabis Supporting Treatments for Neurological Therapies. The aim of the agreement is to make medical cannabis treatments available to patients, with an initial focus on neurological therapies. The market for medical cannabis in Germany.
Cannabis has been identified as an effective alternative treatment for some gastrointestinal disorders…but does that include IBD and IBS? . Diet is used as the primary treatment. . Dronabinol is commonly used as a treatment in cancer patients due to the fact that it can decrease gut transit and increase colon compliance.
As cannabis becomes less stigmatized, the autism community is exploring treatments that are more accessible and less pharmaceutical. THC More Effective Than CBD In Treating Autism, New Preliminary Study Shows. The post THC More Effective Than CBD In Treating Autism, New Preliminary Study Shows appeared first on The Fresh Toast.
Cannabinoids for Inflammatory Skin Diseases To start, consider a recent article in the journal Pharmaceuticals 4 that examines previous research into cannabis-based medicines for inflammatory skin diseases such as acne, 5 eczema, dermatitis, and psoriasis. Suffice to say, they are thorough. After all this, their final take? “It
SEATTLE–(BUSINESS WIRE)–Receptor Life Sciences (RLS), a pharmaceutical company developing innovative therapies to address central nervous system disorders, announced the publication of a manuscript in the Journal of Pharmaceutical Sciences. Social Anxiety Disorder affects about 15 million adults in the U.S.
SciSparc intends to evaluate the efficacy, safety and tolerability of its Proprietary Cannabinoid-Based Treatment- SCI-110. is a specialty clinical-stage pharmaceutical company led by an experienced team of senior executives and scientists. TEL AVIV, Israel , July 26, 2021 /PRNewswire/ — SciSparc Ltd.
While at home in Australia, the Medical Cannabis industry is still working hard to gather more evidence-based research to substantiate treatment assertions, relevant studies are already occurring overseas. It’s heartening to see the release of more and more evidence-based global research surrounding Medical Cannabis-based treatment.
7 The use of cannabis as a cancer treatment was popularized by Rick Simpson, a medical cannabis advocate. In vitro and in vivo studies on THC and cancer THC can induce cell death in various cancer cell lines and experimental animal models, an important role in cancer treatment. Can cannabis fill this void?
Now, a new study has found that medical marijuana (MMJ) shows promise as a treatment for MS. . As with many other conditions, there is a lack of research regarding the use of MMJ as an alternative treatment to relieve symptoms of MS. . The Need for Better MS Treatment. The Need for Better MS Treatment.
It also said any products that make drug or treatment claims also need to be approved by the FDA. The FDA has approved a pharmaceutical version of CBD to treat rare seizure disorders. In December, the agency said CBD is not approved for use in food, drinks and dietary supplements, but noted that could change.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content